EVENTIDE ASSET MANAGEMENT, LLC – Celldex Therapeutics, Inc. Transaction History
EVENTIDE ASSET MANAGEMENT, LLC portfolio value:
$50.36M
portfolio value
EVENTIDE ASSET MANAGEMENT, LLC quarter portfolio value change:
+4.27%
quarter
Celldex Therapeutics, Inc. 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | Increase | +23.94% | 346.1K shares | 11.39M | $28.11 | 1.79M |
| Q2 2022 | share | 0.00% | 0 shares | -10.26M | $26.96 | 1.44M | |
| Q1 2022 | share | Increase | +16.69% | 206.8K shares | 1.37M | $34.06 | 1.44M |
| Q4 2021 | share | Increase | +9.83% | 110.9K shares | -13.03M | $38.9 | 1.23M |
| Q3 2021 | share | Decrease | -46.51% | -980.90K shares | -9.62M | $53.99 | 1.12M |
| Q2 2021 | share | Increase | +2.25% | 46.47K shares | 28.03M | $33.44 | 2.10M |
| Q1 2021 | share | Increase | +12.27% | 225.32K shares | 10.3M | $20.6 | 2.06M |
| Q4 2020 | share | Increase | +262.94% | 1.33M shares | 24.67M | $17.52 | 1.83M |
| Q3 2020 | share | Increase | +9.25% | 42.84K shares | 1.48M | $14.83 | 506.17K |
| Q2 2020 | share | Increase | 0.00% | 463.33K shares | 6.02M | $13 | 463.33K |